McGill Team Lands $5M for Pediatric Glioblastoma Dx Study | GenomeWeb

NEW YORK (GenomeWeb News) – McGill University researchers have received more than C$5 million ($4.9 million) in funding to launch a project that will seek to develop genetic biomarkers for use in treating and improving the quality of life in children with brain cancer, McGill said yesterday.

The researchers plan to develop and deploy a diagnostic test in clinical trials that identifies genetic mutations in glioblastoma patients that could be used to plan treatment strategies and improve quality of life.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.